ETF Holdings Breakdown of ABCL

Stock NameAbcellera Biologics Inc
TickerABCL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINCA00288U1066

News associated with ABCL

Walleye Capital LLC Sells 241,881 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL)
Walleye Capital LLC decreased its position in AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) by 94.2% during the 4th quarter, Holdings Channel reports. The firm owned 15,000 shares of the company’s stock after selling 241,881 shares during the period. Walleye Capital LLC’s holdings in AbCellera Biologics were worth $44,000 at the end of the most […] - 2025-04-29 08:24:53
Federated Hermes Inc. Reduces Stock Holdings in AbCellera Biologics Inc. (NASDAQ:ABCL)
Federated Hermes Inc. reduced its position in shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Free Report) by 59.9% in the 4th quarter, Holdings Channel.com reports. The firm owned 916,237 shares of the company’s stock after selling 1,366,459 shares during the quarter. Federated Hermes Inc.’s holdings in AbCellera Biologics were worth $2,685,000 at the end of […] - 2025-04-14 08:15:08
Reviewing AbCellera Biologics (NASDAQ:ABCL) & Intra-Cellular Therapies (NASDAQ:ITCI)
Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) and AbCellera Biologics (NASDAQ:ABCL – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, profitability and earnings. Analyst Recommendations This is a summary of recent […] - 2025-03-11 06:47:14
Benchmark Reaffirms Hold Rating for AbCellera Biologics (NASDAQ:ABCL)
AbCellera Biologics (NASDAQ:ABCL – Get Free Report)‘s stock had its “hold” rating reissued by stock analysts at Benchmark in a research report issued on Monday,Benzinga reports. ABCL has been the subject of a number of other reports. KeyCorp reduced their target price on shares of AbCellera Biologics from $5.00 to $4.00 and set an “overweight” […] - 2025-03-05 06:56:51
AbCellera Biologics Inc. (NASDAQ:ABCL) Short Interest Up 6.8% in January
AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 18,430,000 shares, an increase of 6.8% from the January 15th total of 17,260,000 shares. Based on an average daily trading volume, of 3,150,000 […] - 2025-02-17 06:10:55

ABCL institutional holdings

The following institutional investment holdings of ABCL have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-09 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 275,276USD 558,810 1.0%
2025-05-09 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 141,198USD 286,632
2025-05-09 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 141,198USD 286,632 1.0%
Total =557,672 USD 1,132,074
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.